Skip to main content

Published locations for CLEOPATRA: Pertuzumab has long-term benefit in HER2+ breast cancer

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. CLEOPATRA: Pertuzumab has long-term benefit in HER2+ breast cancer

User login

  • Reset your password
  • /content/cleopatra-pertuzumab-has-long-term-benefit-her2-breast-cancer
  • /obgynnews/article/219692/breast-cancer/cleopatra-pertuzumab-has-long-term-benefit-her2-breast-cancer
  • /oncologypractice/article/219692/breast-cancer/cleopatra-pertuzumab-has-long-term-benefit-her2-breast
  • /obgyn/article/219692/breast-cancer/cleopatra-pertuzumab-has-long-term-benefit-her2-breast-cancer
  • /hematology-oncology/article/219692/breast-cancer/cleopatra-pertuzumab-has-long-term-benefit-her2
  • /advanced-and-metastatic-breast-cancer/article/219692/breast-cancer/cleopatra-pertuzumab-has-long
  • /breast-cancer-icymi/article/219692/breast-cancer/cleopatra-pertuzumab-has-long-term-benefit-her2